Pricing

Log inSign up

Trevi Therapeutics

1 follower

‌

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Industries

Biotechnology, Education

Headquarters

New Haven, United States

Employees

11-50

Links

Org chart

Jennifer Good
Co-Founder, President & CEO
Collapse
Thomas Sciascia
Co-Founder, Chief Science Officer
Lisa Delfini
CFO
Farrell Simon
Chief Commercial Officer
Katherine Takaki
VP, Global Regulatory Affairs
Katie McManus
Senior Manager, Marketing & Communications
Paula Buckley
VP, Clinical Operations
KF
Kevin Fitzmaurice
Senior Director, Technical Operations
Danine Summers
VP, Medical Affairs

Board & advisors

DM
David Meeker
Chairman
James Cassella
Chief Development Officer (cdo)
DC
Dominick Colangelo
Board Member
Michael Heffernan
Lead Independent Director
EM
Ed Mathers
Board Member
Anne Vanlent
Board Member

Teams

+1

Regulatory and Compliance

5 people · 0 jobs

Leadership Team

3 people · 0 jobs

Medical Affairs and Commercial Strategy

4 people · 0 jobs

KC

Clinical Operations

3 people · 0 jobs

Finance and Accounting

3 people · 0 jobs

Offices

Similar companies

Cellares

4 followers

Tango Therapeutics

3 followers

Dyno Therapeutics

4 followers

Odyssey Therapeutics

2 followers

Gilead Sciences

158 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Explore companies